HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Cerioni Selected Research

Antinuclear Antibodies

2/2003Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Cerioni Research Topics

Disease

1Atherosclerosis
01/2007
1Inflammation (Inflammations)
01/2007
1Rheumatoid Arthritis
11/2006
1Calcinosis
02/2003
1Diffuse Scleroderma (Progressive Systemic Sclerosis)
02/2003
1Ovarian Neoplasms (Ovarian Cancer)
02/2003

Drug/Important Bio-Agent (IBA)

1C-Reactive ProteinIBA
01/2007
1HomocysteineIBA
01/2007
1LipidsIBA
01/2007
1Lipoproteins (Lipoprotein)IBA
01/2007
1Methotrexate (Mexate)FDA LinkGeneric
11/2006
1Adalimumab (Humira)FDA Link
11/2006
1Antirheumatic Agents (DMARD)IBA
11/2006
1Paclitaxel (Taxol)FDA LinkGeneric
02/2003
1Antinuclear AntibodiesIBA
02/2003